Pharmaceutical companies by today's price change
How far the share price has moved since the previous close.
Spyre Therapeutics leads the 61 pharmaceutical companies ranked by today's price change, at +8.21%, ahead of TG Therapeutics (+5.25%) and BioMarin Pharmaceutical (+5.20%). Figures as of 18 Nov 2026, 20:50 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Spyre Therapeutics+8.21%
- Median
- -0.78%
- Combined market value
- SGD 6.53T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Spyre TherapeuticsSYRE · Health Care | +8.21% | SGD 12.4B | SGD 130.90 | 8.21% up | 286% up | ||
| 2 | TG TherapeuticsTGTX · Health Care | +5.25% | SGD 12.9B | SGD 85.11 | 5.25% up | 107% up | ||
| 3 | BioMarin PharmaceuticalBMRN · Health Care | +5.20% | SGD 15.4B | SGD 79.37 | 5.20% up | 11% up | ||
| 4 | Elanco Animal HealthELAN · Health Care | +3.60% | SGD 17.3B | SGD 34.53 | 3.60% up | 20% up | ||
| 5 | Amneal PharmaceuticalsAMRX · Health Care | +3.36% | SGD 9.8B | SGD 28.15 | 3.36% up | 83% up | ||
| 6 | AlkermesALKS · Health Care | +2.87% | SGD 10.1B | SGD 60.29 | 2.87% up | 58% up | ||
| 7 | ZoetisZTS · Health Care | +2.55% | SGD 44.9B | SGD 110.40 | 2.55% up | 29% down | ||
| 8 | Ionis PharmaceuticalsIONS · Health Care | +2.52% | SGD 5.9B | SGD 35.64 | 2.52% up | 64% down | ||
| 9 | Rhythm PharmaceuticalsRYTM · Health Care | +2.33% | SGD 10.7B | SGD 153.87 | 2.33% up | 13% up | ||
| 10 | Jazz PharmaceuticalsJAZZ · Health Care | +2.32% | SGD 20.4B | SGD 317.60 | 2.32% up | 37% up | ||
| 11 | ABIVAXABVX · Health Care | +1.93% | SGD 9.4B | SGD 107.91 | 1.93% up | 27% down | ||
| 12 | Ligand PharmaceuticalsLGND · Health Care | +1.68% | SGD 7.7B | SGD 385.26 | 1.68% up | 43% up | ||
| 13 | Protagonist TherapeuticsPTGX · Health Care | +1.65% | SGD 10.7B | SGD 163.42 | 1.65% up | 46% up | ||
| 14 | Legend BiotechLEGN · Health Care | +1.55% | SGD 4.1B | SGD 21.10 | 1.55% up | 42% down | ||
| 15 | Dr. Reddy's LaboratoriesRDY · Health Care | +1.28% | SGD 16.1B | SGD 19.32 | 1.28% up | 5% up | ||
| 16 | BridgeBio PharmaBBIO · Health Care | +1.15% | SGD 19.5B | SGD 100.18 | 1.15% up | 17% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | +0.67% | SGD 175.8B | SGD 693.48 | 0.67% up | 27% up | ||
| 18 | Praxis Precision MedicinesPRAX · Health Care | +0.61% | SGD 11.1B | SGD 395.77 | 0.61% up | 61% up | ||
| 19 | Arrowhead PharmaceuticalsARWR · Health Care | +0.43% | SGD 7.9B | SGD 55.68 | 0.43% up | 10% up | ||
| 20 | Mirum PharmaceuticalsMIRM · Health Care | +0.22% | SGD 7.8B | SGD 118.83 | 0.22% up | 31% up | ||
| 21 | Abbott LaboratoriesABT · Health Care | -0.03% | SGD 233.8B | SGD 134.99 | 0.03% down | 17% down | ||
| 22 | Roivant SciencesROIV · Health Care | -0.05% | SGD 36.1B | SGD 49.89 | 0.05% down | 90% up | ||
| 23 | Royalty PharmaRPRX · Health Care | -0.06% | SGD 50.9B | SGD 88.51 | 0.06% down | 78% up | ||
| 24 | Cogent BiosciencesCOGT · Health Care | -0.23% | SGD 6.2B | SGD 35.83 | 0.23% down | 20% down | ||
| 25 | Belite BioBLTE · Health Care | -0.31% | SGD 8.2B | SGD 202.76 | 0.31% down | 31% up | ||
| 26 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | -0.32% | SGD 9.6B | SGD 122.26 | 0.32% down | 126% up | ||
| 27 | Ascendis PharmaASND · Health Care | -0.41% | SGD 22.8B | SGD 348.29 | 0.41% down | 28% up | ||
| 28 | ViatrisVTRS · Health Care | -0.54% | SGD 30.1B | SGD 26.23 | 0.54% down | 96% up | ||
| 29 | PTC TherapeuticsPTCT · Health Care | -0.57% | SGD 6.5B | SGD 77.39 | 0.57% down | 20% down | ||
| 30 | Oruka TherapeuticsORKA · Health Care | -0.76% | SGD 8.4B | SGD 123.26 | 0.76% down | 241% up | ||
| 31 | CytokineticsCYTK · Health Care | -0.78% | SGD 9.2B | SGD 66.08 | 0.78% down | 20% down | ||
| 32 | SanofiSNY · Health Care | -0.79% | SGD 146B | SGD 60.81 | 0.79% down | 4% down | ||
| 33 | Definium TherapeuticsDFTX · Health Care | -0.88% | SGD 5.1B | SGD 37.55 | 0.88% down | 169% up | ||
| 34 | United TherapeuticsUTHR · Health Care | -0.90% | SGD 31.8B | SGD 746.43 | 0.90% down | 23% up | ||
| 35 | VeradermicsMANE · Health Care | -0.90% | SGD 6.8B | SGD 160.55 | 0.90% down | 233% up | ||
| 36 | Teva Pharmaceutical IndustriesTEVA · Health Care | -1.01% | SGD 63.5B | SGD 54.40 | 1.01% down | 74% up | ||
| 37 | GSKGSK · Health Care | -1.22% | SGD 125.7B | SGD 62.72 | 1.22% down | 6% up | ||
| 38 | Regeneron PharmaceuticalsREGN · Health Care | -1.27% | SGD 126.1B | SGD 1,219.40 | 1.27% down | 36% up | ||
| 39 | Edgewise TherapeuticsEWTX · Health Care | -1.42% | SGD 5.9B | SGD 53.44 | 1.42% down | 88% up | ||
| 40 | PfizerPFE · Health Care | -1.55% | SGD 206B | SGD 36.15 | 1.55% down | 14% up | ||
| 41 | Summit TherapeuticsSMMT · Health Care | -1.64% | SGD 10.8B | SGD 13.53 | 1.64% down | 36% down | ||
| 42 | GenmabGMAB · Health Care | -1.66% | SGD 40.6B | SGD 65.89 | 1.66% down | 70% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -1.76% | SGD 9.1B | SGD 172.23 | 1.76% down | 7% down | ||
| 44 | InsmedINSM · Health Care | -1.79% | SGD 33.9B | SGD 154.33 | 1.79% down | 40% down | ||
| 45 | Takeda PharmaceuticalTAK · Health Care | -1.83% | SGD 87.5B | SGD 27.40 | 1.83% down | 54% up | ||
| 46 | AstraZenecaAZN · Health Care | -1.90% | SGD 357.6B | SGD 230.57 | 1.90% down | 2% up | ||
| 47 | GrifolsGRFS · Health Care | -1.91% | SGD 7.4B | SGD 10.92 | 1.91% down | 1% up | ||
| 48 | ErascaERAS · Health Care | -1.98% | SGD 6.2B | SGD 17.56 | 1.98% down | 403% up | ||
| 49 | Johnson & JohnsonJNJ · Health Care | -2.00% | SGD 847.8B | SGD 352.19 | 2.00% down | 38% up | ||
| 50 | Travere TherapeuticsTVTX · Health Care | -2.04% | SGD 6.2B | SGD 64.55 | 2.04% down | 44% up | ||
| 51 | Eli LillyLLY · Health Care | -2.24% | SGD 1.59T | SGD 1,784.50 | 2.24% down | 35% up | ||
| 52 | AbbVieABBV · Health Care | -2.38% | SGD 651.5B | SGD 368.60 | 2.38% down | 26% up | ||
| 53 | NovartisNVS · Health Care | -2.39% | SGD 378.3B | SGD 200.30 | 2.39% down | 25% up | ||
| 54 | BeOne MedicinesONC · Health Care | -2.44% | SGD 59.4B | SGD 519.88 | 2.44% down | 17% up | ||
| 55 | Bristol-Myers SquibbBMY · Health Care | -2.84% | SGD 157.1B | SGD 76.87 | 2.84% down | 34% up | ||
| 56 | Novo NordiskNVO · Health Care | -3.01% | SGD 224.4B | SGD 50.90 | 3.01% down | 17% down | ||
| 57 | Corcept TherapeuticsCORT · Health Care | -3.21% | SGD 9.6B | SGD 87.46 | 3.21% down | 8% down | ||
| 58 | Dianthus TherapeuticsDNTH · Health Care | -3.53% | SGD 6.1B | SGD 108.20 | 3.53% down | 113% up | ||
| 59 | Merck & CoMRK · Health Care | -3.93% | SGD 437.8B | SGD 177.61 | 3.93% down | 51% up | ||
| 60 | Alnylam PharmaceuticalsALNY · Health Care | -4.54% | SGD 25.8B | SGD 192.65 | 4.54% down | 66% down | ||
| 61 | Madrigal PharmaceuticalsMDGL · Health Care | -6.16% | SGD 11.9B | SGD 510.66 | 6.16% down | 24% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2895 SGD).
Questions and answers
Which pharmaceutical companies rank first by today's price change?
Spyre Therapeutics (+8.21%), TG Therapeutics (+5.25%) and BioMarin Pharmaceutical (+5.20%) are the top three of the 61 pharmaceutical companies ranked by today's price change as of 18 Nov 2026, 20:50 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by today's price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by today's price change have a combined market value of SGD 6.53T as of 18 Nov 2026, 20:50 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.